BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BioCatalystFeed//bcf//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BioCatalystFeed SKYE catalysts
X-WR-CALDESC:Scheduling/reference data from public records\; dates can move
 . Not investment\, legal or medical advice.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:354ee87d26e55664e8ac@biocat.ai
DTSTAMP:20261118T181353Z
DTSTART;VALUE=DATE:20261120
DTEND;VALUE=DATE:20261121
SUMMARY:SKYE P2 readout (est.): CBeyond
DESCRIPTION:Study to Evaluate the Effect on Obesity of QW Nimacimab and QW 
 Nimacimab Co-administered With Semaglutide vs Placebo\nNCT06577090 | PHASE
 2 | ACTIVE_NOT_RECRUITING | sponsor: Skye Bioscience\, Inc.\nPrimary compl
 etion date (ESTIMATED)\; top-line results usually follow later.\nTicker SK
 YE (confidence 0.9)\nSource: https://clinicaltrials.gov/study/NCT06577090\
 nScheduling/reference data from public records\; dates can move. Not inves
 tment\, legal or medical advice.
TRANSP:TRANSPARENT
URL:https://clinicaltrials.gov/study/NCT06577090
CATEGORIES:readout,ESTIMATED
END:VEVENT
END:VCALENDAR
